BNET Industries
Minrad International Inc. (BUF) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $12.9M
- Profit
- Dec 31 2007
- ($18.7M)
- Market Cap
- Aug 27 2008
- $86.2M
Latest News and Analysis
MINRAD International, Inc. Q1 2008 Conference Call Transcript
MINRAD International, Inc. BUF Q1 2008 Earnings Call
Minrad International Inc. Q4 2007 Earnings Call Transcript
Minrad International Inc. Q4 2007 Earnings Call Transcript
Minrad International Q3 2007 Earnings Call Transcript
Minrad International Q3 2007 Earnings Call Transcript
Additional Resources
MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
ORCHARD PARK, N.Y., Aug. 4 /PRNewswire-FirstCall/ -- MINRAD International, Inc. announced today that the Company will hold an investor conference call to discuss second quarter 2008 financial results on Thursday, August 14, 2008 at 4:30 PM ET. The Company will release second quarter 2008 results prior to the...
BeaconEquity.com Issues TraderNotes on Active Stocks: CABN, NEXC, DFR, CNXTD, XJT, BUF, ONT, FLIR
DALLAS, June 30 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's TraderNotes include: Carbon Sciences Inc. (BULLETIN BOARD: CABN) , NexCen...
Adeka Launches MINRAD Sojourn™ Sevoflurane and SabreSource™
ORCHARD PARK, N.Y., June 12 /PRNewswire-FirstCall/ -- MINRAD International, Inc. today announced Adeka, a large national pharmaceutical company in Turkey with offices located in Istanbul, has recently received government approval to sell MINRAD's SojournTM Sevoflurane inhalation anesthetic in Turkey. Additionally, they have been approved...
MINRAD International, Inc. Announces FDA Approval of Petrem™ Sevoflurane
ORCHARD PARK, N.Y., June 9 /PRNewswire-FirstCall/ -- MINRAD International, Inc. today announced it has received approval from the U.S. Food and Drug Administration Center for Veterinary Medicine to market PetremTM Sevoflurane inhalation anesthetic. This week they have initiated their US product launch to the...
RxElite Announces Implementation of Preferred Contract Status Awarded for Their Anesthetic Gas Products by Physician Sales & Services, Inc.
RxElite, Inc. (OTCBB: RXEI) is pleased toannounce it has received initial orders from Physician Sales and ServicesPSS, for their anesthetic gas products. RxElite was awarded a preferredcontract listing for all classes of trade for Sevoflurane (SojournTM) andIsoflurane (TerrellTM) pursuant to a contract award entered into on March21, 2008. ...
MINRAD Reports Results for First Quarter 2008
Summary: - Revenue of $11.8 million compared to $2.9 million for the first quarter of 2007. - Gross profit of $4.0 million compared with $0.7 million in prior year quarter. - Gross margin was 34% compared to 24% for the first quarter of 2007....
MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
ORCHARD PARK, N.Y., May 8 /PRNewswire-FirstCall/ -- MINRAD International, Inc. announced today that the Company will hold an investor conference call to discuss first quarter 2008 financial results on Tuesday, May 13, 2008 at 4:30 PM ET. The Company will release first quarter 2008 results prior to...
MINRAD International, Inc. Announces $40.0 Million Private Placement
ORCHARD PARK, N.Y., May 5 /PRNewswire-FirstCall/ -- MINRAD International, Inc. today announced that it has entered into agreements to issue and sell an aggregate of $40.0 million of senior secured convertible notes with a group of institutional accredited investors in a private placement. The notes pay an 8%...
RxElite Announces Preferred Contract Status Awarded by National Surgical Hospitals for Their Anesthetic Gas Products
RxElite, Inc. (OTCBB: RXEI) is pleased toannounce the contract award from National Surgical Hospitals, for theiranesthetic gas products. RxElite was awarded a preferred contract listingfor all classes of trade for SojournTMSevoflurane andTerrellTMIsoflurane. Sevoflurane is most commonly used anesthetic gasin the U.S and Isoflurane continues to hold share in the...
RxElite Announces Preferred Contract Status Awarded for Their Anesthetic Gas Products by Nueterra Healthcare
RxElite, Inc. (OTCBB: RXEI) is pleased toannounce that it has been selected by Nueterra Healthcare as a "preferredsupplier" to supply Nueterra Healthcare with anesthetic gas products.Effective February 8, 2008, RxElite was awarded the contract listing forall classes of trade for SojournTM Sevoflurane and TerrellTMIsoflurane. Sevoflurane is...
SPC, BUF, LTS, RTK, SIL, SUF Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-2 April 2008-BUYINS.NET: SPC, BUF, LTS, RTK, SIL, SUF Have Also Been Added To Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:02042008 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and...
MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
ORCHARD PARK, N.Y., Feb. 29 /PRNewswire-FirstCall/ -- MINRAD International, Inc. announced the start of the MINRAD International Distributor Meeting in Cape Town, South Africa. The event will continue through March 2, 2008 and will include two days of presentations and panel discussions by distinguished physicians and researchers...
Dutton Associates Announces Investment Opinion: MINRAD International Rated Strong Speculative Buy in Update Report by Dutton Associates
EL DORADO HILLS, Calif. -- Dutton Associates updates its coverage of MINRAD International (AMEX:BUF), reiterating its Strong Speculative Buy rating and 12-month price target of $5.25. The 21-page report by Dutton Associates senior analyst Sally H. Wallick, CFA, is available at www.jmdutton.com as well as from First...
The Western New York Investors Conference Announces Participating Company Webcast Presentations
BUFFALO, N.Y. -- The Western New York Investors Conference, a two-day event designed to introduce institutional investors and analysts to the publicly held companies from the Western and Upstate New York region, announced today that the following participating companies plan to webcast their presentations on November 6-7:...
Western New York Investors Conference 2007 Announces Bloomberg's Executive Editor as Keynote Speaker
In its fifth year, the annual conference continues to generate investor interest throughout the Northeast, Midwest and Mid-Atlantic regions BUFFALO, N.Y. -- The Founding Committee of the Western New York Investors Conference WNYIC announced today that Rich Jaroslovsky, Executive Editor, Government & Economy, at Bloomberg...
ADL, BUF, AMPL, CWCO, DAKT, HNSN Have Been Removed From Naked Short List Today.
M2 PRESSWIRE-22 August 2007-BUYINS.NET: ADL, BUF, AMPL, CWCO, DAKT, HNSN Have Been Removed From Naked Short List TodayC1994-2007 M2 COMMUNICATIONS LTD RDATE:22082007 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short...
New Regulatory Approval in New Markets Spurs Interest.
M2 PRESSWIRE-6 August 2007-Pinnacle Digest: New Regulatory Approval in New Markets Spurs InterestC1994-2007 M2 COMMUNICATIONS LTD RDATE:06082007 Visit us at www.pinnacledigest.com to gain a more comprehensive and informative approach to the market this company operates within. MINRAD International Inc....
- Next »
- page 1 of 1
- « Previous
Sort byClose
View Related Content by Tag Close
- Incorporated: 1996
- CEO: Mr. William H. Burns Jr.
- Employees: 139
Minrad International operates an interventional pain management business. Specifically, Co. focuses on three areas: anesthesia and analgesia, real-time image guidance and conscious sedation. In addition, Co.'s products are sold throughout the world, primarily in North America, Europe, Asia and Latin America. In the anesthesia and analgesia product line, it manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. Co. sells three modern inhalation anesthetics: isoflurane, enflurane and sevoflurane, through distributors and to original equipment manufacturer (OEM), customers.
Key Competitors
Minrad International Inc. Company Info
Board of Directors
Mr. William H. Burns Jr.
Chairman
Mr. Jeffrey A. Ferrell
Dr. Brett Zbar M.D.
Dr. Theodore H. Stanley M.D.
Mr. David DiGiacinto
Mr. David Donaldson
Mr. Donald F. Farley
Dr. Robert Lifeso M.D.
Mr. Duane Hopper
Contact Information
847 Main Street
Buffalo, NY
716 855-1068